Brief: ReShape Lifesciences Reports Year Ended December 31, 2024 Financial Results and Provides Corporate Update
07/04/2025 21:42
April 7 (Reuters) - ReShape Lifesciences Inc RSLS.O: RESHAPE LIFESCIENCES® REPORTS YEAR ENDED DECEMBER 31, 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE RESHAPE LIFESCIENCES INC: MERGER AGREEMENT WITH VYOME THERAPEUTICS AND ASSET PURCHASE AGREEMENT WITH BIORAD MEDISYS REMAIN ON TRACK Source text: ID:nGNX2lsJCf Further company coverage: RSLS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vyome Holdings
See all newsBrief: Vyome - Appoints Jerry Leonard As CFO On August 27, 2026 - SEC Filing
Biopharma firm Vyome Holdings posts Q2 net loss
Vyome Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Vyome Holdings Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Vyome Strikes Deal With Impetis Biosciences, Opening A ~$57B Market Opportunity